{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:46:54Z","timestamp":1782600414529,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.transci.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T11:47:02Z","timestamp":1557488822000},"page":"484-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management of acquired aplastic anemia in children : A single center experience"],"prefix":"10.1016","volume":"58","author":[{"given":"Arzu","family":"Yazal Erdem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Arman Bilir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Ka\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam\u0131k Ya\u015far","family":"\u00d6zbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcsniye Ne\u015fe","family":"Yaral\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.transci.2019.05.004_bib0005","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.V75.8.1646.1646","article-title":"The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Epidemiology of aplastic anemia in France: a prospective multicenter study","volume":"75","author":"Mary","year":"1990","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.transci.2019.05.004_bib0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3324\/haematol.12020","article-title":"Epidemiology of aplastic anemia: a prospective multicenter study","volume":"93","author":"Montan\u00e9","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2019.05.004_bib0015","series-title":"Lanzkowsky ped. Manual of pediatric hematology and oncology","first-page":"102","article-title":"Bone marrow failure","author":"Lipton","year":"2016"},{"issue":"September (6)","key":"10.1016\/j.transci.2019.05.004_bib0020","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood-2005-03-0874","article-title":"Immunosuppressive therapy for aplastic anemiain children: a more severe disease predicts better survival","volume":"106","author":"F\u00fchrer","year":"2005","journal-title":"Blood"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.05.004_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1986.tb02893.x","article-title":"Aplastic anaemia in the Orient","volume":"62","author":"Young","year":"1986","journal-title":"Br J Haematol"},{"issue":"February (1)","key":"10.1016\/j.transci.2019.05.004_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08880018.2013.807898","article-title":"Outcome of pediatric acquired aplastic anemia: a developing world experience","volume":"31","author":"Ramzan","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.transci.2019.05.004_bib0035","series-title":"Nathan and oski\u2019s hematology of infancy and childhood, philadelphia","first-page":"161","article-title":"Acquired aplastic Anemia and pure Red cell aplasia","author":"Shimamura","year":"2015"},{"issue":"July-August (4)","key":"10.1016\/j.transci.2019.05.004_bib0040","first-page":"342","article-title":"The evaluation of acquired aplastic anemia in children and unexpected frequency of varicella-zoster virus association: a single-center study","volume":"50","author":"Yetgin","year":"2008","journal-title":"Turk J Pediatr"},{"issue":"August (6)","key":"10.1016\/j.transci.2019.05.004_bib0045","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat acquired aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"issue":"April (1)","key":"10.1016\/j.transci.2019.05.004_bib0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2141.2012.09058.x","article-title":"How I manage aplastic anaemia in children","volume":"157","author":"Samarasinghe","year":"2012","journal-title":"Br J Haematol"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.05.004_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"issue":"October (10)","key":"10.1016\/j.transci.2019.05.004_bib0060","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/bmt.2015.153","article-title":"Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia","volume":"50","author":"Kudo","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transci.2019.05.004_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000041000","volume":"103","author":"Bacigalupo","year":"2000","journal-title":"Acta Haematol"},{"issue":"November (7)","key":"10.1016\/j.transci.2019.05.004_bib0070","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1399-3046.2007.00771.x","article-title":"Favorable outcome with allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia patients","volume":"11","author":"Unal","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"May (5)","key":"10.1016\/j.transci.2019.05.004_bib0075","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2014.115345","article-title":"Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis","volume":"100","author":"Bacigalupo","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2019.05.004_bib0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1705894","article-title":"Recent improvement in outcome of unrelated donor transplantation for aplastic anaemia","volume":"41","author":"Viollier","year":"2007","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.transci.2019.05.004_bib0085","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2010-12-327536","article-title":"Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia","volume":"118","author":"Marsh","year":"2011","journal-title":"Blood"},{"issue":"December (11)","key":"10.1016\/j.transci.2019.05.004_bib0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bmt.1705165","volume":"36","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"June (6)","key":"10.1016\/j.transci.2019.05.004_bib0095","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"issue":"June (23)","key":"10.1016\/j.transci.2019.05.004_bib0100","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","article-title":"Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia working Party","volume":"119","author":"Marsh","year":"2012","journal-title":"Blood"},{"issue":"August (5)","key":"10.1016\/j.transci.2019.05.004_bib0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"issue":"October (10)","key":"10.1016\/j.transci.2019.05.004_bib0110","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3324\/haematol.2014.106096","article-title":"Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"99","author":"Dufour","year":"2014","journal-title":"Haematologica"},{"issue":"July- August (4)","key":"10.1016\/j.transci.2019.05.004_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2008-1043875","article-title":"Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German\/Austrian Pediatric Aplastic Anemia Working Group","volume":"210","author":"F\u00fchrer","year":"1998","journal-title":"Klin Padiatr"},{"issue":"August (3)","key":"10.1016\/j.transci.2019.05.004_bib0120","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V100.3.786","article-title":"Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children","volume":"100","author":"Kojima","year":"2002","journal-title":"Blood"},{"issue":"March (9)","key":"10.1016\/j.transci.2019.05.004_bib0125","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","article-title":"Anti thymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome","volume":"289","author":"Rosenfeld","year":"2003","journal-title":"Jama"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.05.004_bib0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0037-1963(00)90033-7","article-title":"Late clonal diseases of treated aplastic anemia","volume":"37","author":"Soci\u00e9","year":"2000","journal-title":"Semin Hematol"},{"issue":"October (1)","key":"10.1016\/j.transci.2019.05.004_bib0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Guidelines for the diagnosis and management of aplastic anaemia","volume":"147","author":"Marsh","year":"2009","journal-title":"Br J Haematol"},{"issue":"May (5)","key":"10.1016\/j.transci.2019.05.004_bib0140","article-title":"Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyteglobulin and cyclosporine","volume":"64","author":"Nishikawa","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"November (8)","key":"10.1016\/j.transci.2019.05.004_bib0145","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MPH.0000000000000647","article-title":"High-dose cyclophosphamide is effective therapy for pediatric severe AplasticAnemia","volume":"38","author":"Gamper","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"October (18)","key":"10.1016\/j.transci.2019.05.004_bib0150","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1182\/blood-2014-05-573642","article-title":"Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution","volume":"124","author":"Scheinberg","year":"2014","journal-title":"Blood"},{"issue":"October (18)","key":"10.1016\/j.transci.2019.05.004_bib0155","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1182\/blood-2014-09-600205","article-title":"Cyclophosphamide in severe aplastic anemia?","volume":"124","author":"Peffault de Latour","year":"2014","journal-title":"Blood"},{"issue":"March (12)","key":"10.1016\/j.transci.2019.05.004_bib0160","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","article-title":"Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug","volume":"123","author":"Desmond","year":"2014","journal-title":"Blood"},{"issue":"March (7958)","key":"10.1016\/j.transci.2019.05.004_bib0165","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(76)90351-2","article-title":"Letter: levamisole and bone-marrow restoration after chemotherapy","volume":"1","author":"Lods","year":"1976","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.transci.2019.05.004_bib0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/bjc.1980.5","article-title":"Levamisole: evidence for activity on human haemopoietic progenitor cells","volume":"41","author":"Senn","year":"1980","journal-title":"Br J Cancer"},{"issue":"August (4)","key":"10.1016\/j.transci.2019.05.004_bib0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjh.12383","article-title":"Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia","volume":"162","author":"Shao","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218303732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218303732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T21:13:56Z","timestamp":1574630036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050218303732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1473050218303732"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.05.004","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of acquired aplastic anemia in children : A single center experience","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}